{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:02:38Z","timestamp":1762506158069},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T00:00:00Z","timestamp":1378944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-417","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T14:15:11Z","timestamp":1378995311000},"source":"Crossref","is-referenced-by-count":28,"title":["A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design"],"prefix":"10.1186","volume":"13","author":[{"name":"The French Research Group of Rectal Cancer Surgery (GRECCAR)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie H","family":"Lefevre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Svrcek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Parc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Tiret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,12]]},"reference":[{"key":"4058_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0399-8320(04)95152-4","volume":"28","author":"AM Bouvier","year":"2004","unstructured":"Bouvier AM, Remontet L, Jougla E: Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004, 28: 877-881. 10.1016\/S0399-8320(04)95152-4.","journal-title":"Gastroenterol Clin Biol"},{"issue":"8496","key":"4058_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986, 1 (8496): 1479-1482.","journal-title":"Lancet"},{"issue":"8843","key":"4058_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","volume":"341","author":"JK MacFarlane","year":"1993","unstructured":"MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet. 1993, 341 (8843): 457-460. 10.1016\/0140-6736(93)90207-W.","journal-title":"Lancet"},{"issue":"8","key":"4058_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1365-2168.2002.02151.x","volume":"89","author":"A Martling","year":"2002","unstructured":"Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T: The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002, 89 (8): 1008-1013. 10.1046\/j.1365-2168.2002.02151.x.","journal-title":"Br J Surg"},{"issue":"2","key":"4058_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/bjs.4834","volume":"92","author":"A Martling","year":"2005","unstructured":"Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B: Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2005, 92 (2): 225-229. 10.1002\/bjs.4834.","journal-title":"Br J Surg"},{"key":"4058_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/978-3-642-83293-2_19","volume":"110","author":"A Gerard","year":"1988","unstructured":"Gerard A, Berrod JL, Pene F, Loygue J, Laugier A, Bruckner R, Camelot G, Arnaud JP, Metzger U, Buyse M, et al: Preoperative radiotherapy and radical surgery as combined treatment in rectal cancer. Recent Results Cancer Res. 1988, 110: 130-133. 10.1007\/978-3-642-83293-2_19.","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"4058_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/1097-0142(19900701)66:1<49::AID-CNCR2820660111>3.0.CO;2-1","volume":"66","author":"Stockholm Rectal Cancer Study Group","year":"1990","unstructured":"Stockholm Rectal Cancer Study Group: Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer. 1990, 66 (1): 49-55.","journal-title":"Cancer"},{"key":"4058_CR8","doi-asserted-by":"crossref","unstructured":"Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical research council rectal cancer working party. Lancet. 1996, 348 (9042): 1605-1610.","DOI":"10.1016\/S0140-6736(96)05348-2"},{"key":"4058_CR9","doi-asserted-by":"crossref","unstructured":"Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish rectal cancer trial. N Engl J Med. 1997, 336 (14): 980-987.","DOI":"10.1056\/NEJM199704033361402"},{"issue":"9","key":"4058_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001, 345 (9): 638-646. 10.1056\/NEJMoa010580.","journal-title":"N Engl J Med"},{"issue":"3","key":"4058_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1200\/JCO.20.3.817","volume":"20","author":"CA Marijnen","year":"2002","unstructured":"Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW: Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002, 20 (3): 817-825. 10.1200\/JCO.20.3.817.","journal-title":"J Clin Oncol"},{"issue":"25","key":"4058_CR12","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","volume":"23","author":"KC Peeters","year":"2005","unstructured":"Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA: Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study. J Clin Oncol. 2005, 23 (25): 6199-6206. 10.1200\/JCO.2005.14.779.","journal-title":"J Clin Oncol"},{"key":"4058_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0399-8320(07)91503-1","volume":"31 Spec No 1","author":"G Portier","year":"2007","unstructured":"Portier G: [Recommendations for clinical practice. Therapeutic choices for rectal cancer. How should neoadjuvant therapies be chosen?]. Gastroenterol Clin Biol. 2007, 31 Spec No 1: 23-33.","journal-title":"Gastroenterol Clin Biol"},{"issue":"11","key":"4058_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006, 355 (11): 1114-1123. 10.1056\/NEJMoa060829.","journal-title":"N Engl J Med"},{"issue":"24","key":"4058_CR15","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","volume":"23","author":"JF Bosset","year":"2005","unstructured":"Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results\u2013EORTC 22921. J Clin Oncol. 2005, 23 (24): 5620-5627. 10.1200\/JCO.2005.02.113.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4058_CR16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004, 240 (4): 711-717.","journal-title":"Ann Surg"},{"issue":"6","key":"4058_CR17","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","volume":"18","author":"LF de Campos-Lobato","year":"2011","unstructured":"de Campos-Lobato LF, Stocchi L, da Luz MA, Geisler D, Dietz DW, Lavery IC, Fazio VW, Kalady MF: Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol. 2011, 18 (6): 1590-1598. 10.1245\/s10434-010-1506-1.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"4058_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/BF02234632","volume":"44","author":"D Medich","year":"2001","unstructured":"Medich D, McGinty J, Parda D, Karlovits S, Davis C, Caushaj P, Lembersky B: Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications. Dis Colon Rectum. 2001, 44 (8): 1123-1128. 10.1007\/BF02234632.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4058_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/01.sla.0000225360.99257.73","volume":"244","author":"NK Kim","year":"2006","unstructured":"Kim NK, Baik SH, Seong JS, Kim H, Roh JK, Lee KY, Sohn SK, Cho CH: Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg. 2006, 244 (6): 1024-1030. 10.1097\/01.sla.0000225360.99257.73.","journal-title":"Ann Surg"},{"issue":"2","key":"4058_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1072-7515(01)01159-0","volume":"194","author":"SP Hiotis","year":"2002","unstructured":"Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg. 2002, 194 (2): 131-135. 10.1016\/S1072-7515(01)01159-0. discussion 135\u2013136","journal-title":"J Am Coll Surg"},{"issue":"8","key":"4058_CR21","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","volume":"17","author":"Y Francois","year":"1999","unstructured":"Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP: Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999, 17 (8): 2396-","journal-title":"J Clin Oncol"},{"issue":"34","key":"4058_CR22","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C Rodel","year":"2005","unstructured":"Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, et al: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005, 23 (34): 8688-8696. 10.1200\/JCO.2005.02.1329.","journal-title":"J Clin Oncol"},{"issue":"28","key":"4058_CR23","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP Gerard","year":"2006","unstructured":"Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006, 24 (28): 4620-4625. 10.1200\/JCO.2006.06.7629.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4058_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1245\/ASO.2006.03.053","volume":"13","author":"F Stipa","year":"2006","unstructured":"Stipa F, Chessin DB, Shia J, Paty PB, Weiser M, Temple LK, Minsky BD, Wong WD, Guillem JG: A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol. 2006, 13 (8): 1047-1053. 10.1245\/ASO.2006.03.053.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4058_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10350-004-6545-x","volume":"46","author":"J Garcia-Aguilar","year":"2003","unstructured":"Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003, 46 (3): 298-304. 10.1007\/s10350-004-6545-x.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4058_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","volume":"236","author":"L Ruo","year":"2002","unstructured":"Ruo L, Tickoo S, Klimstra DS, Minsky BD, Saltz L, Mazumdar M, Paty PB, Wong WD, Larson SM, Cohen AM, et al: Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2002, 236 (1): 75-81. 10.1097\/00000658-200207000-00012.","journal-title":"Ann Surg"},{"issue":"3","key":"4058_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10350-003-0062-1","volume":"47","author":"HG Moore","year":"2004","unstructured":"Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG: Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum. 2004, 47 (3): 279-286. 10.1007\/s10350-003-0062-1.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"4058_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10350-004-6579-0","volume":"46","author":"DE Stein","year":"2003","unstructured":"Stein DE, Mahmoud NN, Anne PR, Rose DG, Isenberg GA, Goldstein SD, Mitchell E, Fry RD: Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum. 2003, 46 (4): 448-453. 10.1007\/s10350-004-6579-0.","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"4058_CR29","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1245\/s10434-008-9892-3","volume":"15","author":"H Tulchinsky","year":"2008","unstructured":"Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M: An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol. 2008, 15 (10): 2661-2667. 10.1245\/s10434-008-9892-3.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4058_CR30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SLA.0b013e3181b91e63","volume":"250","author":"MF Kalady","year":"2009","unstructured":"Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, Fazio VW: Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009, 250 (4): 582-589.","journal-title":"Ann Surg"},{"issue":"2","key":"4058_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31817fc2a0","volume":"248","author":"SB Lim","year":"2008","unstructured":"Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG: Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg. 2008, 248 (2): 243-251. 10.1097\/SLA.0b013e31817fc2a0.","journal-title":"Ann Surg"},{"issue":"6","key":"4058_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/SLA.0b013e3181f3f1b1","volume":"252","author":"SG Yeo","year":"2010","unstructured":"Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH, Park W, Choi DH, Nam H, Kim JS, Cho MJ, et al: Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09\u201301). Ann Surg. 2010, 252 (6): 998-1004. 10.1097\/SLA.0b013e3181f3f1b1.","journal-title":"Ann Surg"},{"issue":"3","key":"4058_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s11605-010-1197-8","volume":"15","author":"LF de Campos-Lobato","year":"2011","unstructured":"de Campos-Lobato LF, Geisler DP, da Luz MA, Stocchi L, Dietz D, Kalady MF: Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg. 2011, 15 (3): 444-450. 10.1007\/s11605-010-1197-8.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"4058_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/DCR.0b013e31823f86cb","volume":"55","author":"K Bujko","year":"2012","unstructured":"Bujko K: Timing of surgery following preoperative therapy in rectal cancer: there is no need for a prospective randomized trial. Dis Colon Rectum. 2012, 55 (3): 31-32.","journal-title":"Dis Colon Rectum"},{"key":"4058_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0399-8320(07)91504-3","volume":"31 Spec No 1","author":"A Rullier","year":"2007","unstructured":"Rullier A, Laurent C: [Recommendations for clinical practice. Therapeutic choices for rectal cancer. What quality criteria are important for surgical excision of rectal cancer?]. Gastroenterol Clin Biol. 2007, 31 Spec No 1: 34-51. 31S91-35","journal-title":"Gastroenterol Clin Biol"},{"issue":"8514","key":"4058_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","volume":"2","author":"P Quirke","year":"1986","unstructured":"Quirke P, Durdey P, Dixon MF, Williams NS: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986, 2 (8514): 996-999.","journal-title":"Lancet"},{"issue":"5","key":"4058_CR37","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1245\/s10434-012-2773-9","volume":"20","author":"H Tranchart","year":"2012","unstructured":"Tranchart H, Lefevre JH, Svrcek M, Flejou JF, Tiret E, Parc Y: What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?. Ann Surg Oncol. 2012, 20 (5): 1551-1559.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4058_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s003840050072","volume":"12","author":"O Dworak","year":"1997","unstructured":"Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997, 12 (1): 19-23. 10.1007\/s003840050072.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"4058_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009, 250 (2): 187-196. 10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg"},{"issue":"2","key":"4058_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240 (2): 205-213. 10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"issue":"6","key":"4058_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/sim.4780100613","volume":"10","author":"P Armitage","year":"1991","unstructured":"Armitage P: Interim analysis in clinical trials. Stat Med. 1991, 10 (6): 925-935. 10.1002\/sim.4780100613. discussion 936\u2013927","journal-title":"Stat Med"},{"key":"4058_CR42","volume-title":"Methodes biostatistiques appliqu\u00e9es \u00e0 la recherche clinique en canc\u00e9rologie","author":"A Kramar","year":"2011","unstructured":"Kramar A, Mathoulin-Pelissier S: Methodes biostatistiques appliqu\u00e9es \u00e0 la recherche clinique en canc\u00e9rologie. 2011, Paris: John Libbey Eurotext"},{"issue":"10","key":"4058_CR43","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/DCR.0b013e3182281f4b","volume":"54","author":"J Evans","year":"2011","unstructured":"Evans J, Tait D, Swift I, Pennert K, Tekkis P, Wotherspoon A, Chau I, Cunningham D, Brown G: Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?. Dis Colon Rectum. 2011, 54 (10): 1251-1259. 10.1097\/DCR.0b013e3182281f4b.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"4058_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/annonc\/mdp340","volume":"21","author":"N Methy","year":"2010","unstructured":"Methy N, Bedenne L, Conroy T, Bouche O, Chapet O, Ducreux M, Gerard JP, Bonnetain F: Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial. Ann Oncol. 2010, 21 (3): 518-524. 10.1093\/annonc\/mdp340.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-417\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T03:14:33Z","timestamp":1646536473000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4058"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-417","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2013,9,12]]},"article-number":"417"}}